U.S. flag

An official website of the United States government

NM_000083.3(CLCN1):c.1437_1450del (p.Pro480fs) AND Congenital myotonia, autosomal recessive form

Germline classification:
Pathogenic/Likely pathogenic (7 submissions)
Last evaluated:
Mar 17, 2026
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002259330.11

Allele description [Variation Report for NM_000083.3(CLCN1):c.1437_1450del (p.Pro480fs)]

NM_000083.3(CLCN1):c.1437_1450del (p.Pro480fs)

Gene:
CLCN1:chloride voltage-gated channel 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7q34
Genomic location:
Preferred name:
NM_000083.3(CLCN1):c.1437_1450del (p.Pro480fs)
Other names:
dbSNP ID: rs768119034
HGVS:
  • NC_000007.14:g.143339288_143339301del
  • NG_009815.2:g.28163_28176del
  • NM_000083.3:c.1437_1450delMANE SELECT
  • NP_000074.3:p.Pro480fs
  • NC_000007.13:g.143036380_143036393del
  • NC_000007.13:g.143036381_143036394del
  • NG_009815.1:g.28163_28176del
  • NM_000083.2:c.1437_1450delACCCTGCGGAGGCT
  • NM_000083.3:c.1437_1450del14MANE SELECT
  • NM_000083.3:c.1437_1450delACCCTGCGGAGGCTMANE SELECT
  • NR_046453.2:n.1392_1405del
  • p.Pro480Hisfs*24
Protein change:
P480fs
Links:
OMIM: 118425.0009; dbSNP: rs768119034
Molecular consequence:
  • NM_000083.3:c.1437_1450del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_046453.2:n.1392_1405del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
3

Condition(s)

Name:
Congenital myotonia, autosomal recessive form
Synonyms:
BECKER DISEASE; Becker Generalized Myotonia
Identifiers:
MONDO: MONDO:0009715; MedGen: C0751360; Orphanet: 614; OMIM: 255700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000039380OMIM
no assertion criteria provided
Pathogenic
(May 1, 2009)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Becker, P. E. Myotonia Congenita and Syndromes associated with Myotonia: Clinical-Genetic Studies of the Nondystrophic Myotonias. Stuttgart: Georg Thieme (pub.) 1977.,

SCV004100818Clinical Omics and Informatics (COIN) Unit, Neuroscience Institute, University Of Cape Town - International Center for Genomic Medicine for Neuromuscular Disease (ICGNMD)
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 22, 2024)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV004171141Institute of Human Genetics, University Hospital of Duesseldorf
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlinenot provided

PubMed (1)
[See all records that cite this PMID]

SCV005038722Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV007580587First Genomix Gene Laboratory, Genetic Diagnostics Department
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 10, 2025)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV007584820Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Mar 17, 2026)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV0076076253billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 26, 2025)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineno1not providednot providednot providednot providedclinical testing
not providedgermlineyes43not providednot providednot providedresearch, not provided, clinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Myotonia levior is a chloride channel disorder.

Lehmann-Horn F, Mailänder V, Heine R, George AL.

Hum Mol Genet. 1995 Aug;4(8):1397-402.

PubMed [citation]
PMID:
7581380

Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians.

Dupré N, Chrestian N, Bouchard JP, Rossignol E, Brunet D, Sternberg D, Brais B, Mathieu J, Puymirat J.

Neuromuscul Disord. 2009 May;19(5):330-4. doi: 10.1016/j.nmd.2008.01.007. Epub 2008 Mar 11.

PubMed [citation]
PMID:
18337100
See all PubMed Citations (7)

Details of each submission

From OMIM, SCV000039380.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In patients with Becker myotonia (255700), Meyer-Kleine et al. (1994) identified a 14-bp deletion in exon 13 of the CLCN1 gene.

In a family in which the index patient and his mother had been examined by Becker (1977), who classified their disorder as dominant myotonia congenita, Lehmann-Horn et al. (1995) found that the proband was homozygous for a 14-bp deletion (involving nucleotides 1437-1450) in exon 13 of the CLCN1 gene. Both nonmyotonic sons of the index patient were heterozygous for the deletion.

In French Canadian patients with recessive myotonia, Dupre et al. (2009) found that homozygosity for the 14-bp deletion resulted in a severe phenotype with generalized hypertrophy, moderate myotonia, and transient weakness.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Clinical Omics and Informatics (COIN) Unit, Neuroscience Institute, University Of Cape Town - International Center for Genomic Medicine for Neuromuscular Disease (ICGNMD), SCV004100818.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (2)

Description

Proband also has heterozygous pathogenic CLCN1 p.Arg894Ter variant (not confirmed in trans).

Description

PM2_supporting: this variant is absent from gnomAD v4.0 (adequate coverage >20X confirmed). The highest population allele frequency in gnomAD v3.1.2 is 0.00016 (0.016%; 11/68038 alleles in European non-Finnish population). PM3_verystrong: this variant has been found in a compound heterozygous state in multiple individuals with AR myotonia congenital (>4 points). PVS1 met: frameshift variant predicted to undergo NMD. Exon is present in a biologically relevant transcript in a gene where LOF is a known mechanism of disease. PS4 met: this variant has been described in more than 10 unrelated probands with consistent phenotype for disorder. Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not provided1not provided

From Institute of Human Genetics, University Hospital of Duesseldorf, SCV004171141.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences, SCV005038722.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedresearch PubMed (2)

Description

The c.1437_1450del (p.(Pro480Hisfs*24)) variant was found in a heterozygous state in 3 Slovak patients with Myotonia congenita and in all of them also the second Likely Pathogenic variant was found: in two of them it was c.2680C>T (p.(Arg894*), whereas in the last one c.2364+2T>C splicing variant. The c.1437_1450del variant is listed as a disease-causing in the HGMD database (CD941645). GnomAD Exomes Version: 4.0 indicates the frequency of f = 0.000121.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided3not provided3not provided

From First Genomix Gene Laboratory, Genetic Diagnostics Department, SCV007580587.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

As part of Carrier Screening testing performed at First Genomix, this variant was identified in a heterozygous state in a patient who is not affected with this condition.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot provided1not providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV007584820.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: CLCN1 c.1437_1450del14 (p.Pro480HisfsX24) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 5.6e-05 in 251488 control chromosomes. This frequency is not significantly higher than estimated for disease-causing variants in CLCN1, allowing no conclusion about variant significance. c.1437_1450del14 has been observed in multiple individuals affected with autosomal recessive myotonia congenita (e.g. Skalova_2013) and in individuals affected with autosomal dominant myotonia congenita (e.g. Richardson_2014). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 24349310, 23893571). ClinVar contains an entry for this variant (Variation ID: 279778). Based on the evidence outlined above, the variant was classified as pathogenic for autosomal recessive and autosomal dominant myotonia congenita.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV007607625.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The variant is observed at an extremely low frequency in the gnomAD v4.1.0 dataset (total allele frequency: 0.012%). Predicted Consequence/Location: Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000279778 /PMID: 7951215 /3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 20, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search